Ftse Mib
37.977,59
0,18%
DAX
22.513,42
-0,43%
S&P 500
6.114,63
-0,01%
NASDAQ
20.026,77
0,41%
Bitcoin
97.260,38
-0,34%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Augmedix Inc (AUGX) Augmedix Inc (AUGX) Notizie

Augmedix Inc

AUGX
2,35
0,00 (0,00%)
14 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/11/202416:31EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
15/10/202415:32EDGAR2Form 15-12G - Securities registration termination [Section..
04/10/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202419:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202419:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202419:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202419:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202419:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202419:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202418:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202418:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
02/10/202415:22EDGAR2Form S-8 POS - Securities to be offered to employees in..
02/10/202415:14EDGAR2Form POS AM - Post-Effective amendments for registration..
02/10/202415:03EDGAR2Form 8-K - Current report
02/10/202414:23GLOBECommure Completes Merger with Augmedix
27/9/202422:47EDGAR2Form 8-K - Current report
16/9/202423:14EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
16/9/202423:12EDGAR2Form 8-K - Current report
29/8/202415:14EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
20/8/202403:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202403:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202403:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202403:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202423:18EDGAR2Form PREM14A - Preliminary proxy statements relating to..
12/8/202422:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202422:07EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/8/202422:07EDGAR2Form 8-K - Current report
12/8/202422:01GLOBEAugmedix Delivers 27% Revenue Growth for Second Quarter of..
06/8/202413:00GLOBEAugmedix to Announce Second Quarter 2024 Financial Results..
24/7/202415:07PRNUSKuehn Law Encourages CHUY, AUGX, BCSA, and HUDA Investors to..
19/7/202413:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/7/202413:36EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/7/202413:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/7/202413:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/7/202413:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/7/202413:25EDGAR2Form 8-K - Current report
19/7/202413:00GLOBEAugmedix to Join Forces with Commure
16/7/202403:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/7/202403:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/6/202418:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
20/6/202413:00GLOBEEmergency Services Inc. Partners with Augmedix to Introduce..
19/6/202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202413:00GLOBEAugmedix Reiterates Second Quarter and Full Year 2024..
29/5/202413:00GLOBEAugmedix Appoints Alex Stinard, M.D., as Chief Clinical AI..
18/5/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 2,35

La tua Cronologia

NASDAQ
AUGX
Augmedix
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci